Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
317 Ergebnisse
| MM5G8B |  | Bristol-Myers Squibb Co./OS/Call [57,5]/MS | - | - | 57,500 | call | Bristol-Myers Squibb Co. | - | 35,619 % | 0,676 | -0,019 | 7,761 | 18.09.2026 | 0,100 | Morgan Stanley | |
| VY46SL | | Bristol-Myers Squibb Co./OS/Call [57,5]/VONT | - | - | 57,500 | call | Bristol-Myers Squibb Co. | - | 38,630 % | 0,692 | -0,026 | 8,906 | 21.08.2026 | 0,100 | Vontobel | |
| VY50MG | | Bristol-Myers Squibb Co./OS/Call [57,5]/VONT | - | - | 57,500 | call | Bristol-Myers Squibb Co. | - | 35,638 % | 0,676 | -0,019 | 7,758 | 18.09.2026 | 0,100 | Vontobel | |
| VY8B88 | Bristol-Myers Squibb Co./OS/Call [57,5]/VONT | - | - | 57,500 | call | Bristol-Myers Squibb Co. | - | 35,419 % | 0,621 | -0,009 | 4,491 | 19.03.2027 | 0,100 | Vontobel | ||
| JE6HKD | Bristol-Myers Squibb Co./OS/Call [58]/JPMD | - | - | 58,000 | call | Bristol-Myers Squibb Co. | - | 34,762 % | 0,611 | -0,008 | 4,611 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE6SWH | Bristol-Myers Squibb Co./OS/Call [58]/JPMD | - | - | 58,000 | call | Bristol-Myers Squibb Co. | - | 34,132 % | 0,623 | -0,011 | 5,671 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE8XWU | Bristol-Myers Squibb Co./OS/Call [58]/JPMD | - | - | 58,000 | call | Bristol-Myers Squibb Co. | - | 37,298 % | 0,604 | -0,010 | 4,981 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE9LZP | Bristol-Myers Squibb Co./OS/Call [58]/JPMD | - | - | 58,000 | call | Bristol-Myers Squibb Co. | - | 35,017 % | 0,609 | -0,007 | 4,025 | 17.06.2027 | 0,100 | JP Morgan | ||
| JY1N8C | Bristol-Myers Squibb Co./OS/Call [58]/JPMD | - | - | 58,000 | call | Bristol-Myers Squibb Co. | - | 36,185 % | 0,676 | -0,026 | 10,194 | 21.08.2026 | 0,100 | JP Morgan | ||
| JY0GD3 | Bristol-Myers Squibb Co./OS/Call [58]/JPMD | - | - | 58,000 | call | Bristol-Myers Squibb Co. | - | 33,411 % | 0,663 | -0,019 | 8,350 | 18.09.2026 | 0,100 | JP Morgan | ||
| PG45KC | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,820 % | 0,577 | -0,012 | 5,674 | 18.12.2026 | 0,100 | BNP Paribas | |
| PL1KQG | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | - | 1,000 | 0,000 | 201,000 | 15.01.2027 | 0,100 | BNP Paribas | |
| PL678L | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | - | - | - | - | 18.09.2026 | 0,100 | BNP Paribas | |
| PL678R | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | - | 1,000 | 0,000 | 201,000 | 17.06.2027 | 0,100 | BNP Paribas | |
| PJ9XDQ | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | - | 1,000 | 0,000 | 201,000 | 19.03.2027 | 0,100 | BNP Paribas | |
| PK0SDD | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | - | 1,000 | 0,000 | 163,162 | 17.09.2027 | 0,100 | BNP Paribas | |
| PK00YN | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,492 % | 0,577 | -0,005 | 3,443 | 17.12.2027 | 0,100 | BNP Paribas | |
| PK50NL | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,847 % | 0,573 | -0,005 | 3,345 | 21.01.2028 | 0,100 | BNP Paribas | |
| PK51Y7 | | Bristol-Myers Squibb Co./OS/Call [60]/BNP | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | - | 1,000 | 0,000 | 185,615 | 17.03.2028 | 0,100 | BNP Paribas | |
| JF000K | Bristol-Myers Squibb Co./OS/Call [60]/JPM | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 36,988 % | 0,552 | -0,010 | 5,300 | 15.01.2027 | 0,100 | JP Morgan | ||
| JZ7U6L | Bristol-Myers Squibb Co./OS/Call [60]/JPMD | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,032 % | 0,563 | -0,011 | 6,071 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE0NL3 | Bristol-Myers Squibb Co./OS/Call [60]/JPMD | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 33,156 % | 0,568 | -0,019 | 9,391 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE55JU | Bristol-Myers Squibb Co./OS/Call [60]/JPMD | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,342 % | 0,565 | -0,009 | 4,894 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE8YJE | Bristol-Myers Squibb Co./OS/Call [60]/JPMD | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 36,888 % | 0,571 | -0,008 | 4,018 | 17.06.2027 | 0,100 | JP Morgan | ||
| JY1J5Z | Bristol-Myers Squibb Co./OS/Call [60]/JPMD | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,068 % | 0,561 | -0,027 | 12,353 | 21.08.2026 | 0,100 | JP Morgan | ||
| JY32PT | Bristol-Myers Squibb Co./OS/Call [60]/JPMD | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 43,120 % | 0,557 | -0,084 | 26,730 | 24.07.2026 | 0,100 | JP Morgan | ||
| MJ8504 | | Bristol-Myers Squibb Co./OS/Call [60]/MS | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,032 % | 0,563 | -0,011 | 6,071 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9J53 | | Bristol-Myers Squibb Co./OS/Call [60]/MS | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,017 % | 0,571 | -0,007 | 4,191 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5G8C | | Bristol-Myers Squibb Co./OS/Call [60]/MS | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,762 % | 0,564 | -0,020 | 9,032 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN022M | | Bristol-Myers Squibb Co./OS/Call [60]/MS | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 36,495 % | 0,575 | -0,006 | 3,376 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6CP4 | | Bristol-Myers Squibb Co./OS/Call [60]/MS | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,473 % | 0,567 | -0,009 | 4,755 | 19.03.2027 | 0,100 | Morgan Stanley | |
| SX5KH0 | Bristol-Myers Squibb Co./OS/Call [60]/SOC | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 33,521 % | 0,565 | -0,019 | 9,329 | 18.09.2026 | 0,100 | Société Générale | ||
| SX5KV1 | Bristol-Myers Squibb Co./OS/Call [60]/SOC | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 36,085 % | 0,553 | -0,010 | 5,409 | 15.01.2027 | 0,100 | Société Générale | ||
| FA53CC | Bristol-Myers Squibb Co./OS/Call [60]/SOC | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,546 % | 0,564 | -0,012 | 5,841 | 18.12.2026 | 0,100 | Société Générale | ||
| FD5HK8 | Bristol-Myers Squibb Co./OS/Call [60]/SOC | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,287 % | 0,566 | -0,009 | 4,899 | 19.03.2027 | 0,100 | Société Générale | ||
| FE1A7G | Bristol-Myers Squibb Co./OS/Call [60]/SOC | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,123 % | 0,568 | -0,007 | 4,289 | 17.06.2027 | 0,100 | Société Générale | ||
| FE1A7K | Bristol-Myers Squibb Co./OS/Call [60]/SOC | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,081 % | 0,568 | -0,006 | 3,800 | 17.09.2027 | 0,100 | Société Générale | ||
| UN3J2W | | Bristol-Myers Squibb Co./OS/Call [60]/UniCredit | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 36,386 % | 0,552 | -0,010 | 5,400 | 13.01.2027 | 0,100 | Unicredit | |
| UN9X0N | | Bristol-Myers Squibb Co./OS/Call [60]/UniCredit | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 32,426 % | 0,579 | -0,007 | 4,408 | 16.06.2027 | 0,100 | Unicredit | |
| VH50E1 | | Bristol-Myers Squibb Co./OS/Call [60]/VONT | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 36,833 % | 0,553 | -0,010 | 5,313 | 15.01.2027 | 0,100 | Vontobel | |
| VJ3CBW | | Bristol-Myers Squibb Co./OS/Call [60]/VONT | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,588 % | 0,575 | -0,011 | 5,862 | 18.12.2026 | 0,100 | Vontobel | |
| VY46PL | | Bristol-Myers Squibb Co./OS/Call [60]/VONT | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,159 % | 0,568 | -0,007 | 4,287 | 17.06.2027 | 0,100 | Vontobel | |
| VY46UK | | Bristol-Myers Squibb Co./OS/Call [60]/VONT | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 37,864 % | 0,555 | -0,030 | 11,269 | 21.08.2026 | 0,100 | Vontobel | |
| VY5J53 | | Bristol-Myers Squibb Co./OS/Call [60]/VONT | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 35,017 % | 0,562 | -0,020 | 8,993 | 18.09.2026 | 0,100 | Vontobel | |
| VY8B83 | Bristol-Myers Squibb Co./OS/Call [60]/VONT | - | - | 60,000 | call | Bristol-Myers Squibb Co. | - | 34,123 % | 0,567 | -0,009 | 4,913 | 19.03.2027 | 0,100 | Vontobel | ||
| MK5REU | | Bristol-Myers Squibb Co./OS/Call [62,5]/MS | - | - | 62,500 | call | Bristol-Myers Squibb Co. | - | 34,962 % | 0,494 | -0,012 | 6,377 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM14BA | | Bristol-Myers Squibb Co./OS/Call [62,5]/MS | - | - | 62,500 | call | Bristol-Myers Squibb Co. | - | 34,533 % | 0,522 | -0,007 | 4,454 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM7NE7 | | Bristol-Myers Squibb Co./OS/Call [62,5]/MS | - | - | 62,500 | call | Bristol-Myers Squibb Co. | - | 34,178 % | 0,448 | -0,019 | 10,394 | 18.09.2026 | 0,100 | Morgan Stanley | |
| VY46SJ | | Bristol-Myers Squibb Co./OS/Call [62,5]/VONT | - | - | 62,500 | call | Bristol-Myers Squibb Co. | - | 37,609 % | 0,411 | -0,028 | 13,258 | 21.08.2026 | 0,100 | Vontobel | |
| VY5J51 | | Bristol-Myers Squibb Co./OS/Call [62,5]/VONT | - | - | 62,500 | call | Bristol-Myers Squibb Co. | - | 33,064 % | 0,477 | -0,019 | 10,164 | 18.09.2026 | 0,100 | Vontobel |